Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Application of fucoidan in the preparation of medicine and health-care products for preventing and treating neurodegenerative diseases

A fucoidan sulfate, neurodegenerative technology, used in nervous system diseases, neuromuscular system diseases, applications, etc.

Inactive Publication Date: 2007-09-26
SHANDONG UNIV
View PDF0 Cites 23 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, according to literature search, there are few reports on the research and application of fucoidan sulfate in nervous system diseases at home and abroad.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0026] Example 1: Preparation of fucoidan sulfate with fresh sea cucumber as raw material.

[0027] Fresh sea cucumber, gutted, washed, broken into 1cm pieces 3 The left and right pieces are homogenized by adding 5-15 times of water.

[0028] The homogenate was subjected to pepsin (the amount of enzyme was 0.4% of the wet weight of sea cucumber, pH 2.0-2.5, temperature 50°C, time 5h), trypsin (the amount of enzyme was 0.45% of the wet weight of sea cucumber, pH 8.0-8.5, Temperature 50°C, time 5h) enzymolysis, after enzymolysis, boiling to inactivate the enzyme activity, centrifugation (10000r / min, 10min) to take the supernatant.

[0029] The supernatant was precipitated with alcohol, centrifuged (6000r / min, 15min) to obtain the precipitate, then dissolved in distilled water, separated through a DEAE cellulose column, and the absorption peak was detected at 210nm, and the active component was collected (using the activity of nerve cells as an index), and lyophilized.

[0030...

Embodiment 2

[0032] Embodiment 2: Preparation of fucoidan sulfate with kelp as raw material

[0033] Lightly dried kelp is washed, dried and pulverized. Weigh a certain weight of powder (50g), add 5 times the volume (250ml) of absolute ethanol to reflux and extract twice, each time for 2 hours, after centrifugation, place the precipitate on a watch glass to evaporate the ethanol.

[0034] Use 5 times volume of acetone (250ml) to reflux extract the kelp powder twice, each time for 2 hours, centrifuge to get the precipitate and evaporate the acetone to dryness. Add 40 times of water (2000ml) and extract in a 70°C water bath for 5 hours, and filter with gauze to obtain the extract. Add 20 times of hydrochloric acid, pH = 6, and extract at 60°C for 6 hours. Concentrate on a rotary evaporator. Precipitate in 30% ethanol overnight, and centrifuge to retain the supernatant. Precipitate overnight in 60% ethanol: centrifuge to retain the precipitate. Freeze-drying to obtain crude fucoidan. Et...

Embodiment 3

[0035] Example 3: Dedifferentiation of neural precursor cells by fucoidan sulfate.

[0036] Wistar rats at 13.5-14 days pregnant were sacrificed by cervical dislocation.

[0037] Isolate and take out the embryos under aseptic conditions, and separate them in a sterile petri dish under a dissecting microscope to obtain nerve cells. Place them in a carbon dioxide incubator at 37°C and 5% carbon dioxide saturated humidity for 48 hours before performing group experiments.

[0038] After the nerve cells were cultured in the 96-well plate for 48 hours, 5 mg / ml of the fucoidan sulfate prepared in Example 1 were added to make the final concentrations of the fucoidan sulfate respectively 100 μg / ml, 200 μg / ml, and 300 μg / ml, 400μg / ml, a negative control group (blank), and a positive control group for nerve growth factor. Incubate for 48 hours at 37°C, 5% carbon dioxide saturated humidity.

[0039] The analysis results showed that fucoidan sulfate had obvious dedifferentiation effect...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses a fucose sulfate or a compound whose active component is fucose sulfate, in the drug preparation on the treatment of nerve retrograde disease and cognition damage. And the invention discloses the relative application. The inventive fucose sulfate is mainly from marine invertebrate animal as sea-tangle, sea cucumber or the like, with wide resource, easy production, batch production, and wide application.

Description

Technical field [0001] The invention belongs to the field of biomedicine. In particular, it relates to the application of fucoidan sulfate in the preparation of drugs or health care products for preventing and treating neurodegenerative diseases. Background technique [0002] Nervous system degenerative diseases are diseases that seriously endanger people's health. Currently, about 1 billion people in the world are sick due to damage to the nervous system. Neurodegenerative diseases include a variety of diseases, such as common Alzheimer’s disease (AD), Parkinson’s disease (PD), etc. Most of these diseases develop progressively and are a type of disease whose etiology and pathogenesis are still unclear. Its pathological characteristics are atrophy and neuron loss of nerve nuclei with specific functions. Clinically, there are no effective measures to control the progression of this type of disease, and patients will eventually lose their ability to live or even die. [00...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): A61K31/737A61K9/08A61K9/20A61K9/48A61K8/73A61P21/00A61P25/14A61P25/16A61P25/28A23L1/30A23L2/38C08B37/00
Inventor 吉爱国宋淑亮宋迪
Owner SHANDONG UNIV
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com